Literature DB >> 28477641

Pulmonary Function and Pretransplant Evaluation of the Hematopoietic Cell Transplant Candidate.

Guang-Shing Cheng1.   

Abstract

Pretransplant pulmonary function tests provide baseline data by which to reference subsequent respiratory impairment, as well as important prognostic information, for the hematopoietic cell transplant (HCT) recipient. Abnormalities in forced expiratory volume in 1 second and diffusing capacity of carbon monoxide are associated with early respiratory failure and increased all-cause mortality after allogeneic HCT. These parameters have been incorporated into risk assessment calculators that may aid in clinical decision making. This article discusses the clinical implications of pulmonary function parameters and other risk factors for pulmonary complications in the context of evolving allogeneic HCT practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DLCO; FEV(1); Hematopoietic cell transplantation; Pretransplant evaluation; Pulmonary complications; Pulmonary function tests; Risk assessment

Mesh:

Year:  2017        PMID: 28477641     DOI: 10.1016/j.ccm.2016.12.014

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidates.

Authors:  Matt S Zinter; A Birgitta Versluys; Caroline A Lindemans; Madeline Y Mayday; Gustavo Reyes; Sara Sunshine; Marilynn Chan; Elizabeth K Fiorino; Maria Cancio; Sabine Prevaes; Marina Sirota; Michael A Matthay; Sandhya Kharbanda; Christopher C Dvorak; Jaap J Boelens; Joseph L DeRisi
Journal:  Sci Transl Med       Date:  2022-03-09       Impact factor: 19.319

2.  Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors.

Authors:  Giana Berleze Penna; Tassiana Costa da Silva; Alessandra Aparecida Paz; Bruna Ziegler
Journal:  Support Care Cancer       Date:  2021-01-04       Impact factor: 3.359

Review 3.  Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation.

Authors:  Vivek N Ahya
Journal:  Clin Chest Med       Date:  2017-09-19       Impact factor: 2.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.